Lipopolysaccharide induction of cyclooxygenase-2 in long-term nasal epithelial cultures in cystic fibrosis
- PMID: 20403848
- DOI: 10.1001/archoto.2010.28
Lipopolysaccharide induction of cyclooxygenase-2 in long-term nasal epithelial cultures in cystic fibrosis
Abstract
Objective: To evaluate the lipopolysaccharide induction of cyclooxygenase-2 (COX-2) in long-term epithelial cultures from nasal polyp tissue of patients with cystic fibrosis (CF) and severe nasal polyposis.
Design: Experimental and histologic study.
Setting: Department of Otorhinolaryngology, University of Ulm, Ulm, Germany.
Participants: Nasal polyp tissue was evaluated from 9 patients with CF and obstructing nasal polyps undergoing elective sinus surgery. Nasal mucosa from the hypertrophic inferior turbinate of 9 patients without a history of CF or aspirin intolerance undergoing nasal corrective surgery served as control specimens.
Interventions: Tissue culturing, Western blotting, and tissue staining with hematoxylin-eosin.
Main outcome measures: The expression and lipopolysaccharide induction of COX-2 was detected and compared with those of the control group. Tissue was analyzed for the presence of inflammatory cells such as neutrophils, eosinophils, mast cells, plasma cells, lymphocytes, and monocytes.
Results: COX-2 was detectable in tissue specimens from all of the patients with CF and control subjects. In patients with CF, however, COX-2 expression was significantly lower in lipopolysaccharide-stimulated, long-term cultured epithelial cells compared with control tissue. Polyps from patients with CF contained markedly more neutrophils, macrophages, and plasma cells than did nasal mucosa from hypertrophic inferior turbinates of controls.
Conclusions: COX-2 expression in lipopolysaccharide-stimulated, long-term cultured epithelial cells in patients with CF is decreased compared with that in hypertrophic turbinate mucosa. The estimated defect in lipopolysaccharide responsiveness and the reduced induction of COX-2 needs further investigation.
Similar articles
-
Cyclooxygenase 2 and lipoxin A₄ in nasal polyps in cystic fibrosis.Am J Rhinol Allergy. 2011 Nov-Dec;25(6):e251-4. doi: 10.2500/ajra.2011.25.3726. Am J Rhinol Allergy. 2011. PMID: 22185734
-
Expression of cyclooxygenase and lipoxygenase enzymes in sinonasal mucosa of patients with cystic fibrosis.Arch Otolaryngol Head Neck Surg. 2008 Aug;134(8):825-31. doi: 10.1001/archotol.134.8.825. Arch Otolaryngol Head Neck Surg. 2008. PMID: 18711055
-
Degranulation of cystic fibrosis nasal polyp mast cells.J Pathol. 1992 Apr;166(4):395-404. doi: 10.1002/path.1711660412. J Pathol. 1992. PMID: 1517893
-
Expression of cyclooxygenase and lipoxygenase enzymes in nasal polyps of aspirin-sensitive and aspirin-tolerant patients.Arch Otolaryngol Head Neck Surg. 2006 Jun;132(6):579-87. doi: 10.1001/archotol.132.6.579. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16785401
-
Pathogenesis and management of nasal polyposis in cystic fibrosis.Curr Allergy Asthma Rep. 2012 Apr;12(2):163-74. doi: 10.1007/s11882-012-0250-y. Curr Allergy Asthma Rep. 2012. PMID: 22350539 Review.
Cited by
-
Release of cyclooxygenase-2 and lipoxin A4 from blood leukocytes in aspirin-exacerbated respiratory disease.Allergy Rhinol (Providence). 2016 Jan 1;7(3):158-163. doi: 10.2500/ar.2016.7.0172. Allergy Rhinol (Providence). 2016. PMID: 28107149 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials